| Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study L Perreault, Q Pan, KJ Mather, KE Watson, RF Hamman, SE Kahn The Lancet 379 (9833), 2243-2251, 2012 | 557 | 2012 |
| Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program LM Delahanty, Q Pan, KA Jablonski, VR Aroda, KE Watson, GA Bray, ... Diabetes Care 37 (10), 2738-2745, 2014 | 144 | 2014 |
| Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program LM Delahanty, Q Pan, KA Jablonski, KE Watson, JM McCaffery, ... Diabetes care 35 (2), 363-366, 2012 | 134 | 2012 |
| Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial H Florez, Q Pan, RT Ackermann, DG Marrero, E Barrett-Connor, ... Journal of general internal medicine 27, 1594-1601, 2012 | 117 | 2012 |
| Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the Diabetes Prevention Program and the Look AHEAD randomized controlled trials GD Papandonatos, Q Pan, NM Pajewski, LM Delahanty, I Peter, B Erar, ... Diabetes 64 (12), 4312-4321, 2015 | 85 | 2015 |
| Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired … WH Herman, Q Pan, SL Edelstein, KJ Mather, L Perreault, ... Diabetes Care 40 (12), 1668-1677, 2017 | 75 | 2017 |
| Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS) L Perreault, Q Pan, EB Schroeder, RR Kalyani, GA Bray, S Dagogo-Jack, ... Diabetes care 42 (9), 1809-1815, 2019 | 71 | 2019 |
| Effect of metformin and lifestyle interventions on mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study CG Lee, B Heckman-Stoddard, D Dabelea, KM Gadde, D Ehrmann, ... Diabetes care 44 (12), 2775-2782, 2021 | 64 | 2021 |
| Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study D Marrero, Q Pan, E Barrett-Connor, M de Groot, P Zhang, C Percy, ... Quality of Life Research 23, 75-88, 2014 | 57 | 2014 |
| Diabetes Prevention Program Research Group Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes … L Perreault, Q Pan, KJ Mather, KE Watson, RF Hamman, SE Kahn Lancet 379 (9833), 2243-2251, 2012 | 55 | 2012 |
| The impact of physical activity on the prevention of type 2 diabetes: evidence and lessons learned from the diabetes prevention program, a long-standing clinical trial … AM Kriska, B Rockette-Wagner, SL Edelstein, GA Bray, LM Delahanty, ... Diabetes Care 44 (1), 43-49, 2021 | 53 | 2021 |
| Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer X Tan, Z Li, S Ren, K Rezaei, Q Pan, AT Goldstein, CJ Macri, D Cao, ... Breast Cancer Research 21, 1-14, 2019 | 52 | 2019 |
| Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS) L Perreault, Q Pan, VR Aroda, E Barrett‐Connor, D Dabelea, ... Diabetic Medicine 34 (12), 1747-1755, 2017 | 50 | 2017 |
| Variation at the melanocortin 4 receptor gene and response to weight‐loss interventions in the diabetes prevention program Q Pan, LM Delahanty, KA Jablonski, WC Knowler, SE Kahn, JC Florez, ... Obesity 21 (9), E520-E526, 2013 | 47 | 2013 |
| Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program TI Pollin, T Isakova, KA Jablonski, PIW De Bakker, A Taylor, J McAteer, ... Public Library of Science 8 (8), e1002895, 2012 | 47 | 2012 |
| Mixture models for undiagnosed prevalent disease and interval‐censored incident disease: applications to a cohort assembled from electronic health records LC Cheung, Q Pan, N Hyun, M Schiffman, B Fetterman, PE Castle, ... Statistics in medicine 36 (22), 3583-3595, 2017 | 33 | 2017 |
| Proportional hazards models based on biased samples and estimated selection probabilities Q Pan, DE Schaubel Canadian Journal of Statistics 36 (1), 111-127, 2008 | 33 | 2008 |
| Efficient utilization of the expanded criteria donor (ECD) deceased donor kidney pool: an analysis of the effect of labeling RA Hirth, Q Pan, DE Schaubel, RM Merion American Journal of Transplantation 10 (2), 304-309, 2010 | 28 | 2010 |
| Association of intensive lifestyle and metformin interventions with frailty in the diabetes prevention program outcomes study HP Hazuda, Q Pan, H Florez, JA Luchsinger, JP Crandall, EM Venditti, ... The Journals of Gerontology: Series A 76 (5), 929-936, 2021 | 22 | 2021 |
| Metabolite profiles of incident diabetes and heterogeneity of treatment effect in the diabetes prevention program ZZ Chen, J Liu, J Morningstar, BM Heckman-Stoddard, CG Lee, ... Diabetes 68 (12), 2337-2349, 2019 | 22 | 2019 |
